Handzande and BOC Star Venture Jointly Release White Paper on the Application of Intelligent Technologies in Synthetic Biology
Globally, bio-manufacturing technologies, represented by synthetic biology, are leading a new industrial revolution. According to the previously released 《National Biotechnology and Biomanufacturing Initiative》，By the end of this century, bio-ManufacturingMay account for more than one-third of global manufacturing output— Valued at nearly $30 trillion. The Global Industrial Sector Stands at the Forefront of a Biotechnology-Driven Industrial Revolution, Major Countries and RegionsLoadingScaling Up Synthetic Biology Technologies and the Biomanufacturing Industry, biomanufacturing has become a key priority for countries around the world to develop competitively，Moreover, it is essential to maintain firm control over core technologies and other critical assets.
Synthetic biology is currently sweeping across various industries with an unstoppable momentum, spanning health, materials, agriculture, food, energy, and even military applications. According to estimates from BCC Research, the global synthetic biology market is projected to grow from $9.5 billion in 2021 to $33.2 billion in 2026, representing a compound annual growth rate (CAGR) of 28.4% during the 2021–2026 forecast period. Driven by emerging policy opportunities, market potential, and capital incentives, synthetic biology is entering a new phase of rapid development.
As the functions and potential applications of synthetic biology continue to expand, the complexity of its implementation and the demand for interdisciplinary expertise are rapidly increasing. However, living systems are exceedingly intricate, characterized by high dynamics, flexibility, nonlinearity, and unpredictability. How to accurately predict and design such systems remains a core challenge facing synthetic biology.
On August 3, at the 5th China International Biopharmaceutical & Chemical Pharmaceutical Expo in 2023,Dr. He Dan, Chief Marketing Officer of HanzandiandMs. Zhu Beili, Director of Proxima VenturesJointly Released"White Paper on the Application of Intelligent Technologies in Synthetic Biology", and provided an analysis of the latest trends in synthetic biology.
White Paper on the Application of Intelligent Technologies in Synthetic BiologyThis article provides a brief overview of the synthetic biology industry, explores the application and future prospects of intelligence in this field, and aims to assist researchers in executing the “Design-Build-Test-Learn” (DBTL) cycle with high efficiency, low cost, and multiple iterations. The ultimate goal is to enhance operational efficiency across all stages of synthetic biology, reduce costs, shorten R&D cycles, and expand the possibilities for research and development.
Scan the QR code to download the White Paper on Applications of Intelligent Technologies in Synthetic Biology
Hanzandi has developed an intelligent, end-to-end solution for synthetic biology by integrating automated equipment, intelligent control software, and data management systems. This solution enables fully automated operations across the entire workflow—from biological sample storage and retrieval, DNA component assembly, cell screening and cultivation, to product detection—significantly enhancing efficiency for both industrial and academic sectors.
In the future, Hanzandi will be committed to building an integrated platform based on automated standalone units and intelligent operating systems, promoting efficiency improvements in synthetic biology from R&D to industrialization, achieving full-process intelligence in synthetic biology, and empowering the robust growth of synthetic biology enterprises.
